Tag: patent

ASHBURN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Verizon Frontline today announced that two more industry partners have joined the growing list of companies whose products have earned “Verizon Frontline Verified” status. With Radiav and Siyata now part of the "Verizon Frontline Verified" program, Verizon continues to demonstrate its commitment to providing proven 5G-enabled solutions built for first responders.

THORNTON, Colo., July 16, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies (“Ascent” or the “Company”) (Nasdaq: ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced it has entered into an agreement to supply a Colorado-based power systems provider with the Company’s thin-film PV technology for evaluation and potential incorporation into the provider’s established array product offering. Ascent will deliver the units for evaluation before the end of July 2025, demonstrating its market-leading speed to fulfill orders.

Mit erstklassigen Beratern, modernster Genomik und Echtzeit-KI zielt die Sportgesundheitsplattform auf Herzkomplikationen, Verletzungen durch Überanstrengung, fehlerhafte Teamauswahl und ungenutztes Talent ab

Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ^® by EMA’s safety committee (PRAC).

HOUSTON, July 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present at the Advanced Wound Care Summit USA in Boston, Massachusetts, on July 15, 2025. The presentation will include recent research advances using fibroblast-based technology for indications such as wound healing and psoriasis.